Market Overview The Mexico Growth Hormone Deficiency Clinical Trials Market was valued at approximately USD 98 Million in 2023 and is expected to grow at a CAGR of 4.9% from 2024 to 2030, reaching nearly USD 136.98 Million by 2030. The market is gaining importance as healthcare providers, pharmaceutical companies, clinical research organizations, and research...